 |
 |

Methylphenidate vs Dextroamphetamine vs Caffeine in Minimal Brain DysfunctionControlled Comparison by Placebo Washout Design With Bayes' Analysis
L. Eugene Arnold, MD;
James Christopher, MD;
Robert Huestis, MD;
Donald J. Smeltzer, MA
Arch Gen Psychiatry. 1978;35(4):463-473.
Abstract
Double-blind crossover comparison of methylphenidate hydrochloride, dextroamphetamine sulfate, and caffeine after placebo washout in 29 children with minimal brain dysfunction (MBD) showed on six ratings that methylphenidate and dextroamphetamine were significantly (P <.05 to P <.001) better than placebo and caffeine, but not significantly (P <.05) different from each other. Placebo, caffeine, and ratings before drug did not differ significantly. Of 26 drug responders, 12 responded best to dextroamphetamine, ten to methylphenidate, and one to caffeine. The latter child showed no improvement at all with either prescription stimulant. Methylphenidate and dextroamphetamine were each efficacious for six children who did not respond to the other stimulant. All three drugs showed significant (P <.05) weight loss and cardiovascular side effects, the latter possibly spurious. Dextroamphetamine showed a significant (P <.05) decrease from placebo in "tummyaches."
Author Affiliations
From the Division of Child Psychiatry, Ohio State University.
Footnotes
Accepted for publication March 31, 1977.
Reprint requests to Division of Child Psychiatry, Department of Psychiatry, Ohio State University, 473 W 12th Ave, Columbus, OH 43210 (Dr Arnold).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults
Greenhill et al.
Focus 2004;2:642-668.
ABSTRACT
| FULL TEXT
Efficacy of a Mixed Amphetamine Salts Compound in Adults With Attention-Deficit/Hyperactivity Disorder
Spencer et al.
Arch Gen Psychiatry 2001;58:775-782.
ABSTRACT
| FULL TEXT
Effects of caffeine on cognitive, psychomotor, and affective performance of children with Attention-Deficit/Hyperactivity Disorder
Leon
J Atten Disord 2000;4:27-47.
ABSTRACT
Methyiphenidate vs. amphetamine: Comparative review
Arnold
J Atten Disord 2000;3:200-211.
ABSTRACT
Mouse Model of Hyperkinesis Implicates SNAP-25 in Behavioral Regulation
Hess et al.
J. Neurosci. 1996;16:3104-3111.
ABSTRACT
| FULL TEXT
Behavioral and Cognitive Effects of Methylxanthines: A Meta-analysis of Theophylline and Caffeine
Stein et al.
Arch Pediatr Adolesc Med 1996;150:284-288.
ABSTRACT
The Role of Methylphenidate in Psychiatry
Klein and Wender
Arch Gen Psychiatry 1995;52:429-433.
ABSTRACT
Attention-Deficit Hyperactivity Disorder
Laird and Saklad
Journal of Pharmacy Practice 1990;3:241-251.
ABSTRACT
The Health Consequences of Caffeine
CURATOLO and ROBERTSON
ANN INTERN MED 1983;98:641-653.
ABSTRACT
Psychotropic Drugs and Learning Problems--A Selective Review
Aman
J Learn Disabil 1980;13:87-97.
ABSTRACT
Megavitamins for Minimal Brain Dysfunction: A Placebo-Controlled Study
Arnold et al.
JAMA 1978;240:2642-2643.
ABSTRACT
|